All News Earnings_Preview LRCX $293.42

LRCX Earnings Oct 21: $2.18 EPS Expected, Key Levels to Watch

Lam Research reports Oct 21 with consensus EPS of $2.18 (+73% YoY) and $8.13B revenue expected. Stock trades at $290, down 17.6% from its recent high. Here's what the options market signals.

The setup heading into Lam Research's October 21 earnings is mixed-to-cautious: a deteriorating near-term chart, heavy put accumulation near current prices, and a stock sitting 17.6% off its recent peak โ€” yet underpinned by explosive analyst estimate revisions and one of the strongest fundamental growth profiles in semiconductor equipment. The tension between a genuine fundamental upgrade cycle and a technical breakdown makes this one of the more asymmetric setups in the sector this earnings season.

LRCX price chart with options gamma levels ahead of 2026-10-21 earnings

The Setup: Sellers Have Had Control Since Early October

LRCX has shed roughly $57 in just nine sessions, falling from a recent high of $352.56 on October 2 to $290.49 as of Wednesday's open โ€” a decline of 17.6% that places it below its 20-day moving average of $314.04 and its 50-day at $311.11. The 5-day trend is firmly down, down 8.62% over that span, and the stock is printing inside a descending channel with no clear floor established yet.

The broader context matters here. Tuesday's sector selloff was driven in part by Applied Materials declining to provide a spending forecast at its investor day, rattling the entire semiconductor equipment cohort. LRCX, KLA, and AMAT all dropped 4โ€“7% in a single session โ€” a sector-wide de-rating, not company-specific news. That distinction is worth keeping in mind as we approach the print.

On the longer-term view, the 100-day trend is a moderate downtrend (price change: -0.37% over the period), with major support at $229.77 and resistance at $338.28. The trendline scanner has flagged a Converging Wedge pattern with a bullish signal, suggesting the compression between $290.90 support and $352.56 resistance could resolve to the upside โ€” but a catalyst is needed to confirm it, and earnings in six days is exactly that catalyst.

What the Options Market Says

Options flow carries an interesting split signal. The overall flow score registers at 68/100, classified as "accumulation" โ€” suggesting that despite the price weakness, institutional money has been buying options exposure rather than abandoning the name. However, the structure of that positioning skews defensively.

Pre-earnings put accumulation is concentrated and aggressive. The $290 strike has seen open interest build of 22,550 contracts, and the $240 strike has absorbed nearly 12,885 contracts of new put exposure. By contrast, the largest call build is at the $385 strike (5,646 contracts) and $390 (4,014 contracts). The asymmetry of this positioning โ€” heavy downside hedging close to the current price โ€” suggests the options market is pricing in meaningful downside risk heading into the print.

The gamma wall structure defines the dealer-positioning corridor. The call wall sits at $350 (open interest: 73,535 contracts) and the put wall at $280 (103,661 contracts). These levels represent the strikes where dealer hedging flows are most concentrated and are likely to act as gravitational zones in either direction. The put wall at $280 carries notably higher open interest than the call wall, reinforcing the bearish lean in near-term positioning.

The gamma context from the earnings analysis puts the implied dealer range at $280โ€“$350. This corridor โ€” a spread of roughly $70 around a midpoint near $315 โ€” frames the likely containment zone for the post-earnings reaction absent a major surprise in either direction. RSI sits at 41.7, not quite oversold but getting there, which could limit the pain on a modest miss.

Fundamentals & Estimates: The Bull Case Is Intact

Whatever the chart says short-term, the fundamental setup for LRCX remains genuinely compelling. The current-quarter consensus EPS estimate stands at $2.18, implying 72.8% year-over-year growth versus the year-ago figure of $1.26. Revenue consensus is $8.13 billion, up an estimated 52.8% year-over-year from $5.32 billion. These are not incremental beats โ€” this is an inflection-level growth quarter if management delivers.

Critically, analyst estimate revisions have been running entirely one-directional. Over the past 30 days, there have been 50 upward EPS revisions and zero downward revisions โ€” as clean a momentum signal as you'll see. The full-year 2026 EPS consensus has risen from $8.11 ninety days ago to $9.48 today, a 16.8% upgrade in under three months. Next quarter's consensus is already pricing in 82% year-over-year EPS growth at $2.31.

On valuation, LRCX trades at a forward P/E of 33.7x with a PEG ratio of 1.45 โ€” reasonable given the growth trajectory, though not cheap in absolute terms. Return on equity is a robust 65.1% and net profit margin stands at 31.3%. The Wall Street consensus price target of $375.81 (median: $385.00) implies 29.4% upside from current levels, with ratings skewing heavily bullish: 25 buys, 4 strong buys, 6 holds, and zero sells.

LRCX sits in an oligopoly position within the semiconductor equipment supply chain, supplying etch and deposition tools to TSMC, Samsung, Intel, Micron, and GlobalFoundries. Its bottleneck score of 8/10 reflects a structurally advantaged position โ€” customers cannot easily substitute its tools for key process steps. That moat is the reason the long-term bull case persists even through sector-level turbulence.

Key Levels to Watch

Level Price Significance
Call Wall / Upside Resistance $350.00 73,535 contracts OI; recovery target on a strong beat
100-Day Resistance $338.28 First major technical ceiling on any post-earnings rally
20-Day Resistance $331.79 Reclaiming this level would signal short-term trend repair
Current Price $290.49 Below both 20-day and 50-day moving averages
20-Day Support / Pattern Floor $290.90 Converging wedge base; critical near-term hold
Put Wall / Downside Magnet $280.00 103,661 contracts OI; likely floor on an in-line quarter
Analyst Price Target Low $290.00 Street's most bearish single target โ€” already at current price
Long-Term Support $229.77 100-day trendline floor; only relevant on a severe miss

If LRCX fails to hold the $280 put wall on a disappointing result or cautious forward guidance โ€” particularly around WFE (wafer fabrication equipment) spending outlook โ€” the next meaningful technical support on the 100-day chart does not materialize until $229.77. The gap between $280 and $230 contains limited structure, making a guidance miss the higher-stakes scenario here.

Bottom Line

LRCX enters earnings with a paradox: one of the cleanest estimate revision trends in semiconductor equipment (50 upgrades, zero downgrades over 30 days; full-year EPS consensus up 16.8% in 90 days) colliding with a stock that has already corrected 17.6% from its high and sits just above its heaviest put concentration. If management delivers the $2.18 EPS / $8.13B revenue print and provides constructive commentary on 2027 WFE spending, the converging wedge pattern resolves bullishly toward $331โ€“$350. A miss or cautious guide โ€” given where put open interest is concentrated โ€” risks a swift test of $280. With 29 of 35 analysts at buy or strong buy and a mean target of $375.81, the Street's conviction is clear. The question is whether October 21 is where the fundamental story reasserts itself over the sector-driven technical damage.

Want this analysis for any stock, on demand? Ask Alpha Assistant โ€” AI analysis backed by live scores, options flow, gamma walls and supply-chain data.

This article was generated by Tradestie Alpha Assistant using live market data (investment scores, options positioning, trendlines, and fundamentals) and reviewed before publication. It is for informational purposes only and is not financial advice. Do your own research before making investment decisions.

Share Post LinkedIn
Tradestie Research

Signal-driven market analysis backed by live scanner hit rates, options positioning, and supply-chain data. Every claim is checked against the numbers before it's published. Browse all analysis →